Cyclobenzaprine hydrochloride (BioDeep_00000717857)

   


代谢物信息卡片


Cyclobenzaprine hydrochloride

化学式: C20H22ClN (311.14406820000005)
中文名称: 环苯扎林盐酸盐
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CN(C)CC/C=C1C2=CC=CC=C2C=CC3=CC=CC=C\13.Cl
InChI: 1H

描述信息

D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents
C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
Cyclobenzaprine hydrochloride (MK130 hydrochloride) is a skeletal muscle relaxant with activity on the central nervous system.

同义名列表

3 个代谢物同义名

Cyclobenzaprine hydrochloride; MK130 hydrochloride; Cyclobenzaprine (hydrochloride)



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Cihangir Buyukgoz, Shantaveer Gangu, Faaria Gowani, Dai Kimura. Treatment of comatose patient from cyclobenzaprine overdose with therapeutic plasma exchange. Journal of clinical apheresis. 2022 Jun; 37(3):313-315. doi: 10.1002/jca.21960. [PMID: 34953071]
  • Mitchelle Katemauswa, Ekram Hossain, Zongyuan Liu, Mahbobeh Lesani, Adwaita R Parab, Danya A Dean, Laura-Isobel McCall. Enabling Quantitative Analysis of Surface Small Molecules for Exposomics and Behavioral Studies. Journal of the American Society for Mass Spectrometry. 2022 Mar; 33(3):412-419. doi: 10.1021/jasms.1c00263. [PMID: 35084848]
  • Haidara Majid, Andreas Puzik, Tanja Maier, Daniel Eberhard, Anke Bartel, Hans-Christian Mueller, Bjoern B Burckhardt. Exploring the transmucosal permeability of cyclobenzaprine: A comparative preformulation by standardized and controlled ex vivo and in vitro permeation studies. International journal of pharmaceutics. 2021 May; 601(?):120574. doi: 10.1016/j.ijpharm.2021.120574. [PMID: 33831487]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Judy Caron, Randall Kaye, Thomas Wessel, Amy Halseth, Gary Kay. An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine. Journal of clinical pharmacy and therapeutics. 2020 Aug; 45(4):774-782. doi: 10.1111/jcpt.13165. [PMID: 32390248]
  • Mehran Haidari, Sravan Mansani, Dezaray Ponds, Lissett Romero, Christine Cobb, Saad Alsaab. Storage of urine specimens in point of care (POC) urine drug testing cups reduces concentrations of many drugs. Clinica chimica acta; international journal of clinical chemistry. 2019 Dec; 499(?):81-86. doi: 10.1016/j.cca.2019.09.001. [PMID: 31491368]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • M I Walash, S A El Abass Mohamed. Green analytical chromatographic assay method for quantitation of cyclobenzaprine in tablets, spiked human urine and in-vitro dissolution test. Annales pharmaceutiques francaises. 2019 Sep; 77(5):418-425. doi: 10.1016/j.pharma.2019.06.004. [PMID: 31296331]
  • Mohammad Hassan Baig, Safikur Rahman, Gulam Rabbani, Mohd Imran, Khurshid Ahmad, Inho Choi. Multi-Spectroscopic Characterization of Human Serum Albumin Binding with Cyclobenzaprine Hydrochloride: Insights from Biophysical and In Silico Approaches. International journal of molecular sciences. 2019 Feb; 20(3):. doi: 10.3390/ijms20030662. [PMID: 30717459]
  • Liat Adar, William Zarycranski, Jill B Conner, Jeffrey Dragone, Lindsay Janka, Laura Rabinovich-Guilatt. Bioequivalence of cyclobenzaprine hydrochloride extended-release capsule taken intact or sprinkled over applesauce
. International journal of clinical pharmacology and therapeutics. 2017 Dec; 55(12):931-938. doi: 10.5414/cp203059. [PMID: 29092731]
  • Michele A Glinn, Andrew J Lickteig, Luke Weber, Sherri Recer, Matthew Salske, Audrey Harvey, Brian Rappold, Julie Stensland, Patrick Bell. Urinary Concentrations of Topically Administered Pain Medications. Journal of analytical toxicology. 2017 Mar; 41(2):127-133. doi: 10.1093/jat/bkw110. [PMID: 28376226]
  • Kaylee R Mastrianni, L Andrew Lee, William E Brewer, Nagaraju Dongari, Michael Barna, Stephen L Morgan. Variations in enzymatic hydrolysis efficiencies for amitriptyline and cyclobenzaprine in urine. Journal of analytical toxicology. 2016 Nov; 40(9):732-737. doi: 10.1093/jat/bkw062. [PMID: 27405366]
  • Kelly Ann Scanlon, Robert Stoppacher, Lee M Blum, Samantha J Starkey. Comprehensive Duloxetine Analysis in a Fatal Overdose. Journal of analytical toxicology. 2016 Mar; 40(2):167-70. doi: 10.1093/jat/bkv134. [PMID: 26662354]
  • Michael S Westrol, Nadia I Awad, Patrick J Bridgeman, Erika Page, Jonathan V McCoy, Janos Jeges. Use of an Intravascular Heat Exchange Catheter and Intravenous Lipid Emulsion for Hypothermic Cardiac Arrest After Cyclobenzaprine Overdose. Therapeutic hypothermia and temperature management. 2015 Sep; 5(3):171-6. doi: 10.1089/ther.2015.0006. [PMID: 26154529]
  • Jenny L Chua-Tuan, Dazhe Cao, Janetta L Iwanicki, Christopher O Hoyte. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report. Clinical toxicology (Philadelphia, Pa.). 2015 Jul; 53(6):565-8. doi: 10.3109/15563650.2015.1040157. [PMID: 25951877]
  • Sonia Hernández-Díaz, Yung-Cheng Su, Allen A Mitchell, Katherine E Kelley, Antonia M Calafat, Russ Hauser. Medications as a potential source of exposure to phthalates among women of childbearing age. Reproductive toxicology (Elmsford, N.Y.). 2013 Jun; 37(?):1-5. doi: 10.1016/j.reprotox.2013.01.001. [PMID: 23333816]
  • Tatiane Maria de Lima Souza Brioschi, Simone Grigoleto Schramm, Eunice Kazue Kano, Eunice Emiko Mori Koono, Ting Hui Ching, Cristina Helena Dos Reis Serra, Valentina Porta. Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets. BioMed research international. 2013; 2013(?):281392. doi: 10.1155/2013/281392. [PMID: 24151591]
  • Yi Xiang, Liping Zhou, Zhenyu Qian, Kelong Peng, Dongyan Li, Xiaomei Chen, Hongliang Jiang, Heng Zheng. Determination of cyclobenzaprine in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry and its application in a pharmacokinetic study. Biomedical chromatography : BMC. 2012 Sep; 26(9):1083-8. doi: 10.1002/bmc.1751. [PMID: 22120786]
  • Ney Carter Borges, Vinicius Marcondes Rezende, Jose Marcos Santana, Ricardo Pereira Moreira, Roberto Fernandes Moreira, Patrícia Moreno, Diego Carter Borges, José Luiz Donato, Ronilson Agnaldo Moreno. Chlorpromazine quantification in human plasma by UPLC-electrospray ionization tandem mass spectrometry. Application to a comparative pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2011 Dec; 879(31):3728-34. doi: 10.1016/j.jchromb.2011.10.020. [PMID: 22074958]
  • J Mestres, S A Seifert, T I Oprea. Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome. Clinical pharmacology and therapeutics. 2011 Nov; 90(5):662-5. doi: 10.1038/clpt.2011.177. [PMID: 21975349]
  • Nesrin K Ramadan, Hala E Zaazaa, Hanan A Merey. Microsized graphite sensors for potentiometric determination of cyclobenzaprine hydrochloride in pure powder, tablets, and plasma. Journal of AOAC International. 2011 Nov; 94(6):1807-14. doi: 10.5740/jaoacint.10-361. [PMID: 22320088]
  • Yasuto Kido, Pär Matsson, Kathleen M Giacomini. Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. Journal of medicinal chemistry. 2011 Jul; 54(13):4548-58. doi: 10.1021/jm2001629. [PMID: 21599003]
  • Mona Darwish, Edward T Hellriegel. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers. Clinical therapeutics. 2011 Jun; 33(6):746-53. doi: 10.1016/j.clinthera.2011.05.045. [PMID: 21704239]
  • Mona Darwish, Edward T Hellriegel. Pharmacokinetic profile of once-daily cyclobenzaprine extended-release. Expert opinion on drug metabolism & toxicology. 2010 Nov; 6(11):1425-36. doi: 10.1517/17425255.2010.523419. [PMID: 20883117]
  • M N Gai, E Costa, A Arancibia. Bioavailability of a controlled-release cyclobenzaprine tablet and influence of a high fat meal on bioavailability. International journal of clinical pharmacology and therapeutics. 2009 Apr; 47(4):269-74. doi: 10.5414/cpp47269. [PMID: 19356393]
  • Mona Darwish, Steven Chang, Edward T Hellriegel. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers. Clinical therapeutics. 2009 Jan; 31(1):108-14. doi: 10.1016/j.clinthera.2009.01.014. [PMID: 19243711]
  • Mona Darwish, Fang Xie. Comparison of the single-dose pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg and cyclobenzaprine immediate-release 10 mg three times daily in the elderly: a randomized, open-label, crossover study. Drugs & aging. 2009; 26(2):95-101. doi: 10.2165/0002512-200926020-00001. [PMID: 19220066]
  • Mona Darwish, Fang Xie. Effect of food on the pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg: a randomized, open-label, crossover, single-centre study. Clinical drug investigation. 2009; 29(3):145-52. doi: 10.2165/00044011-200929030-00001. [PMID: 19243207]
  • Mona Darwish, Edward T Hellriegel, Fang Xie. Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults : a randomized, open-label, two-period crossover, single-centre study. Clinical drug investigation. 2008; 28(12):793-801. doi: 10.2165/0044011-200828120-00007. [PMID: 18991473]
  • Gregory A Winchell, Joyce D King, Cynthia M Chavez-Eng, Marvin L Constanzer, Scott H Korn. Cyclobenzaprine pharmacokinetics, including the effects of age, gender, and hepatic insufficiency. Journal of clinical pharmacology. 2002 Jan; 42(1):61-9. doi: 10.1177/0091270002042001007. [PMID: 11808825]
  • E L Michalets, L K Smith, E D Van Tassel. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction. The Annals of pharmacotherapy. 1998 Jul; 32(7-8):761-5. doi: 10.1345/aph.17351. [PMID: 9681092]
  • E C Wong, J Koenig, J Turk. Potential interference of cyclobenzaprine and norcyclobenzaprine with HPLC measurement of amitriptyline and nortriptyline: resolution by GC-MS analysis. Journal of analytical toxicology. 1995 Jul; 19(4):218-24. doi: 10.1093/jat/19.4.218. [PMID: 8531466]
  • M Constanzer, C Chavez, B Matuszewski. Development and comparison of high-performance liquid chromatographic methods with tandem mass spectrometric and ultraviolet absorbance detection for the determination of cyclobenzaprine in human plasma and urine. Journal of chromatography. B, Biomedical applications. 1995 Apr; 666(1):117-26. doi: 10.1016/0378-4347(94)00556-k. [PMID: 7655609]
  • A Poklis, L E Edinboro. REMEDi drug profiling system readily distinguishes between cyclobenzaprine and amitriptyline in emergency toxicology urine specimens. Clinical chemistry. 1992 Nov; 38(11):2349-50. doi: NULL. [PMID: 1424145]
  • D Hamaty, J L Valentine, R Howard, C W Howard, V Wakefield, M S Patten. The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study. The Journal of rheumatology. Supplement. 1989 Nov; 19(?):164-8. doi: . [PMID: 2532682]
  • M L Constanzer, W C Vincek, W F Bayne. Determination of cyclobenzaprine in plasma and urine using capillary gas chromatography with nitrogen-selective detection. Journal of chromatography. 1985 May; 339(2):414-8. doi: 10.1016/s0378-4347(00)84673-3. [PMID: 4008581]
  • P S Heckerling, T J Bartow. Paradoxical diaphoresis in cyclobenzaprine poisoning. Annals of internal medicine. 1984 Dec; 101(6):881. doi: 10.7326/0003-4819-101-6-881_1. [PMID: 6497211]
  • A E Till, M L Constanzer, J Demetriades, J D Irvin, R B Lee, R K Ferguson. Evidence for route dependent biotransformation of cyclobenzaprine hydrochloride. Biopharmaceutics & drug disposition. 1982 Jan; 3(1):19-28. doi: 10.1002/bdd.2510030104. [PMID: 7082776]
  • H B Hucker, A J Balletto, B H Arison, A G Zacchei. Metabolism of cyclobenzaprine in the dog. Drug metabolism and disposition: the biological fate of chemicals. 1978 Mar; 6(2):184-92. doi: . [PMID: 26535]
  • H B Hucker, S C Stauffer, K S Albert, B W Lei. Plasma levels and bioavailability of cyclobenzaprine in human subjects. Journal of clinical pharmacology. 1977 Nov; 17(11-12):719-27. doi: 10.1002/j.1552-4604.1977.tb01547.x. [PMID: 925191]
  • H B Hucker, S C Stauffer. Gas-liquid chromatographic determination of nanogram amounts of cyclobenzaprine in plasma using a nitrogen detector. Journal of chromatography. 1976 Sep; 124(1):164-8. doi: 10.1016/s0021-9673(00)87860-7. [PMID: 965452]
  • G Belvedere, C Pantarotto, V Rovei, A Frigerio. Identification of 10, 11-epoxide and other cyclobenzaprine metabolites isolated from rat urine. Journal of pharmaceutical sciences. 1976 Jun; 65(6):815-21. doi: 10.1002/jps.2600650606. [PMID: 932964]
  • H J Hilderson, M J De Wolf, A R Lagrou, W S Dierick. Subcellular structure of bovine thyroid gland. A study on bovine thyroid membranes by buoyant-density-gradient centrifugation in a B-XIV zonal rotor. The Biochemical journal. 1975 Dec; 152(3):601-7. doi: 10.1042/bj1520601. [PMID: 5997]